Dana-Farber Cancer Research, Teaching Affiliate, Harvard Medical School
World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us
Newly Approved Targeted Drug Makes 79% Of Patients' Tumours Disappear Altogether, This Type Of Blood Tumour Is Saved!
New CAR-T Therapy CB-010, Granted Two FDA Designations And Three Patients Are Cancer-Free For Six Months!
Immune And Astrazeneca Launch Strategic Research Collaboration To Accelerate Drug Target Discovery
How To Cope With The Cold Weather For Those With a Yang Deficiency Constitution
